These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21482799)

  • 1. Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta.
    Louis JV; Martens E; Borghgraef P; Lambrecht C; Sents W; Longin S; Zwaenepoel K; Pijnenborg R; Landrieu I; Lippens G; Ledermann B; Götz J; Van Leuven F; Goris J; Janssens V
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6957-62. PubMed ID: 21482799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of protein phosphatase 2A (PP2A) complexity reveals cellular functions and dephosphorylation motifs of the PP2A/B'δ holoenzyme.
    Jong CJ; Merrill RA; Wilkerson EM; Herring LE; Graves LM; Strack S
    J Biol Chem; 2020 Apr; 295(17):5654-5668. PubMed ID: 32156701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning and differential expression patterns of the regulatory subunit B' gene of PP2A in goldfish, Carassius auratus.
    Fu H; Ma H; Zheng C; Lü J; Yu X; Li C; Peng Y; Liao G; Liu W; Xiao Y; Liu Y; Li DW
    Sci China C Life Sci; 2009 Aug; 52(8):724-32. PubMed ID: 19727590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
    J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
    Hallows JL; Chen K; DePinho RA; Vincent I
    J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein phosphatase 2A regulatory subunits B'beta and B'delta mediate sustained TrkA neurotrophin receptor autophosphorylation and neuronal differentiation.
    Van Kanegan MJ; Strack S
    Mol Cell Biol; 2009 Feb; 29(3):662-74. PubMed ID: 19029245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
    J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
    Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
    J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
    Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
    J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
    Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal bisphenol A exposure contributes to Tau pathology: Potential roles of CDK5/GSK3β/PP2A axis in BPA-induced neurotoxicity.
    Xue J; Zhang L; Xie X; Gao Y; Jiang L; Wang J; Wang Y; Gao R; Yu J; Xiao H
    Toxicology; 2020 May; 438():152442. PubMed ID: 32278051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase activities increase during the development of tauopathy in htau mice.
    Kelleher I; Garwood C; Hanger DP; Anderton BH; Noble W
    J Neurochem; 2007 Dec; 103(6):2256-67. PubMed ID: 17908241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Single-Dose and Long-Term Ketamine Administration on Tau Phosphorylation-Related Enzymes GSK-3β, CDK5, PP2A, and PP2B in the Mouse Hippocampus.
    Li Y; Wen G; Ding R; Ren X; Jing C; Liu L; Yao J; Zhang G; Lu Y; Li B; Wu X
    J Mol Neurosci; 2020 Dec; 70(12):2068-2076. PubMed ID: 32705526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
    Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
    J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK5 activator protein p25 preferentially binds and activates GSK3β.
    Chow HM; Guo D; Zhou JC; Zhang GY; Li HF; Herrup K; Zhang J
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4887-95. PubMed ID: 25331900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.
    Tang Z; Bereczki E; Zhang H; Wang S; Li C; Ji X; Branca RM; Lehtiö J; Guan Z; Filipcik P; Xu S; Winblad B; Pei JJ
    J Biol Chem; 2013 May; 288(22):15556-70. PubMed ID: 23585566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level.
    Sengupta A; Novak M; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 2006 Oct; 580(25):5925-33. PubMed ID: 17045592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.
    Wisely EV; Xiang YK; Oddo S
    Hum Mol Genet; 2014 Aug; 23(15):4024-34. PubMed ID: 24626633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of tau aggregation by cdk5 and GSK3β.
    Lee S; Hall GF; Shea TB
    J Alzheimers Dis; 2011; 26(2):355-64. PubMed ID: 21677377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.